Marinomed Biotech AG
MARI.VI · VIE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €26,675 | €44,331 | €84,538 | €129,875 |
| - Cash | €1,706 | €2,589 | €8,175 | €5,802 |
| + Debt | €29,504 | €21,797 | €22,628 | €15,798 |
| Enterprise Value | €54,472 | €63,540 | €98,990 | €139,871 |
| Revenue | €4,747 | €9,184 | €11,276 | €11,628 |
| % Growth | -48.3% | -18.6% | -3% | – |
| Gross Profit | -€4,268 | €1,143 | €2,141 | €1,424 |
| % Margin | -89.9% | 12.4% | 19% | 12.2% |
| EBITDA | -€7,181 | -€3,623 | -€3,213 | -€3,576 |
| % Margin | -151.3% | -39.4% | -28.5% | -30.8% |
| Net Income | -€15,416 | -€6,795 | -€6,398 | -€5,891 |
| % Margin | -324.8% | -74% | -56.7% | -50.7% |
| EPS Diluted | -8.67 | -4.5 | -4.27 | -3.99 |
| % Growth | -92.7% | -5.4% | -7% | – |
| Operating Cash Flow | – | -€4,528 | -€5,203 | -€4,866 |
| Capital Expenditures | – | -€129 | -€228 | -€919 |
| Free Cash Flow | – | -€4,657 | -€5,431 | -€5,785 |